| 英文名称 |
中文名称 |
CAS |
|
5-hydroxy methyl-2'-dC; 5-hydroxymethyl-2'-deoxycytidine
|
|
7226-77-9 |
|
2'-dX; 2'-deoxyxanthosine
|
|
29049-22-7 |
|
N-[2-[[[4-(2,2-Dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]-(S)-glycine monosodium salt
|
|
150374-95-1 |
|
5-Bromoindole-2-carboxylic acid
|
|
7254-19-5 |
|
1,3,2-Dioxathiolane, 4-Methyl-, 2,2-dioxide, (4R)-
|
|
1006381-03-8 |
|
2'-deoxy-3'-GMP·Na2; 2'-Deoxyguanosine-3'-monophosphate, disodium salt
|
|
102814-03-9 |
|
(4-Chloro-7H-pyrrolo[2,3-d]pyrimidin-7-yl)methyl pivalate
|
|
1146629-75-5 |
|
(3aR,7aR)-4'-(benzo[d]isothiazol-3-yl)octahydrospiro[isoindole-2,1'-piperazin]-2-ium4-methylbenzenesulfonate
|
|
1907680-83-4 |
|
N4-NH2-Cr; N4-aminocytidine
|
|
57294-74-3 |
|
Azathramycin
|
|
76801-85-9 |
|
Octanoic acid, 8-[(2-hydroxybenzoyl)amino]-, ethyl ester
|
|
1027911-46-1 |
|
Methyl 4-(butyrylamino)-3-methyl-5-nitrobenzoate
|
|
152628-01-8 |
|
4-Chlorophthalic acid
|
|
89-20-3 |
|
5-I-2'-O-Me-Cr; 5-Iodo-2'-O-methyl-cytidine
|
|
847650-69-5 |
|
1-(dichloroacetyl)-1,2,3,4-tetrahydroquinolin-6-ol
|
|
62265-67-2 |
|
3-Buten-1-ol
|
|
627-27-0 |
|
2-NH2-purine-riboside; 2-amino Purine Riboside
|
|
4546-54-7 |
|
5-Methoxysalicylic acid
|
|
2612-02-4 |
|
Valbenazine tosylate
|
|
1639208-54-0 |
|
1-benzyl-4-hydroxy-2-methyl-1H-benzo[d]imidazole-6-carboxylic acid
|
|
1640981-19-6 |
|
D-4-Hydroxyphenylglycine Methyl ester hydrochloride
|
|
57591-61-4 |
|
Trometamolthioctic acid
|
|
14538-90-8 |
|
4-Hydroxy-L-phenylglycine
|
|
32462-30-9 |
|
1-(4-Aminophenyl)cyclopentanecarbonitrile
|
|
115279-73-7 |
|
[(4-methoxyphenyl)methyl] hydrogen (4-hydroxyphenyl)malonate
|
|
78641-40-4 |
|
potassium decanoate
|
|
13040-18-1 |
|
HEX Dye Amidite; 5'-Hexachloro-Fluorescein Phosphoramidite; 6-(4, 7, 2', 4', 5', 7'-Hexachloro-3', 6'-dipivaloylfluoresceinyl-6-carboxamido)-hexyl-1-O-[(2-cyanoethyl)-(N, N-diisopropyl)]-phosphoramidite
|
|
64742-82-1 |
|
2,5-Dibromophenylacetic acid
|
|
203314-28-7 |
|
Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-, ethyl ester, monohydrochloride
|
|
211914-50-0 |
|
2'-deoxy-3'-UMP·Na2; 2'-Deoxyuridine-3'-monophosphate, Disodium salt
|
|
102783-59-5 |
|
(S)-(-)-4-ISOPROPYL-5,5-DIPHENYL-2-OXAZOLIDINONE
|
|
184346-45-0 |
|
1-benzothien-2-yl(5-bromo-2-fluorophenyl)methanol
|
|
1034305-11-7 |
|
(R)-((2R,5S)-5-(4-aminobenzyl)pyrrolidin-2-yl)(phenyl)methanol
|
|
1295539-30-8 |
|
8-((3R,4S)-4-ethylpyrrolidin-3-yl)-3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazine
|
|
1708997-43-6 |
|
5-Methyl-7-methoxyisoflavone
|
|
82517-12-2 |
|
8-AMinooctanoic acid HCl
|
|
27991-81-7 |
|
(R)-(+)-4-ISOPROPYL-5,5-DIPHENYL-2-OXAZOLIDINONE
|
|
191090-32-1 |
|
Octanoic acid, 8-[(5-chloro-2-hydroxybenzoyl)amino]-
|
|
204852-67-5 |
|
(Z)-ethyl (2-cyano-2-(2-(3,5-dichloro-4-((5-isopropyl-6-oxo-1,6-dihydropyridazin-3-yl)oxy)phenyl)hydrazono)acetyl)carbamate(WXG00198)
|
|
920509-33-7 |
|
2-Piperidone
|
|
675-20-7 |
|
tert-Butyl rosuvastatin
|
|
355806-00-7 |
|
Methyl 4-methoxysalicylate
|
|
5446-02-6 |
|
(4R-cis)-6-Chloromethyl-2,2-dimethyl-1,3-dioxane-4-acetic Acid tert-Butyl Ester
|
|
154026-94-5 |
|
1-(2-Methoxyphenyl)piperazine hydrochloride
|
|
5464-78-8 |
|
2'-methylene-dU; 2'-Deoxy-2'-methylene-uridine
|
|
|
|
2'-N3-2'-dC; 2'-Azido-2'-deoxycytidine
|
|
51034-68-5 |
|
Sitagliptin N-Boc IMpurity
|
|
486460-23-5 |
|
N-(tert-butoxycarbonyl)dopamine
|
|
37034-31-4 |
|
Sodium(S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylate
|
|
1421271-01-3 |
|
6-methylmercapto-9-(β-D-ribofuranosyl)purine; 6-methylmercapto-9-(β-D-ribofuranosyl)purine
|
|
342-69-8 |
|
iso-Gr; iso-Guanosine
|
|
1818-71-9 |
|
2',3'-cAMP·Na; Adenosine 2', 3'-cyclic-monophosphate, sodium salt
|
|
37063-35-7 |
|
1H-Benzimidazole-6-carboxamide, 4-hydroxy-N,N,2-trimethyl-1-(phenylmethyl)-
|
|
1640981-20-9 |
|
Erythromycin A Oxime
|
|
111321-02-9 |
|
5-formyl-2'-dU; 5-formyl-2'-deoxyuridine
|
|
4494-26-2 |
|
1-(4-Aminophenoxy)-3-ethoxy-2-propanol
|
|
94056-98-1 |
|
2,2'-cyclo-CMP; 2, 2'-Cyclocytidine 5'-monophosphate, free acid
|
|
39679-56-6 |
|
2-[1-(2-Fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyriMidine-4,5,6-triaMine
|
|
428854-24-4 |
|
3',5'-cGMP·Na; Guanosine 3', 5'-cyclic-monophosphate, sodium salt
|
|
40732-48-7 |
|
2,5-dichloro-N'-hydroxy-4,6-dimethylnicotinimidamide
|
|
896125-90-9 |
|
Phenylmethyl (3R,4S)-3-[2-[[(1,1-dimethylethoxy)carbonyl][5-[(4-methylphenyl)sulfonyl]-5H-pyrrolo[2,3-b]pyrazin-2-yl]amino]acetyl]-4-ethyl-1-pyrrolidinecarboxylate
|
|
1428243-27-9 |
|
1,3(2H,4H)-Isoquinolinedione, 7-methoxy-2-methyl-
|
|
76746-95-7 |
|
2,5-dichloro-3-[5-(3,4-dimethoxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl]-4,6-dimethylpyridine (innovative process)
|
|
2356241-50-2 |
|
1-Piperazinecarboxylic acid, 2,6-diMethyl-, 1,1-diMethylethyl ester, (2S,6S)-
|
|
574007-66-2 |
|
2-[[(3aR,4S,6R,6aS)-6-[7-Bromo-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]tetrahydro-2,2-dimethyl-4H-cyclopenta-1,3-dioxol-4-yl]oxy]-acetic acid methyl ester
|
|
274693-24-2 |
|
3',5'-cGMP; Guanosine 3', 5'-cyclic-monophosphate, free acid
|
|
7665-99-8 |
|
2-Thio-Ur; 2-Thio-uridine
|
|
20235-78-3 |
|
2-(1-HydroxyCyclohexyl)-2-(4-MethoxyPhenyl)Acetonitrile
|
|
93413-76-4 |
|
3,5-Dibromo-4-hydroxybenzoic acid
|
|
3337-62-0 |
|
4-(2-BroMoethyl)-1,3-dihydro-2H-indolin-2-one
|
|
120427-96-5 |
|
pU; Pseudouridine
|
|
1445-07-4 |
|
3'-AMP·H2; Adenosine-3'-monophosphate, free acid
|
|
84-21-9 |
|
N-Despropyl GaMithroMycin
|
|
145388-07-4 |
|
Isoquinoline, 3,4-dihydro-6,7-di(methoxy-d3)-, hydrochloride (1:1)
|
|
1783808-87-6 |
|
3,4-Dihydroxyphenylacetic acid
|
|
102-32-9 |
|
iso-dG; iso-deoxyguanosine
|
|
106449-56-3 |
|
3,4-dimethoxy-5-nitrobenzoic acid (innovative process)
|
|
91004-48-7 |
|
4-CHLOROSULFONYLPHENYLPIVALATE
|
|
150374-99-5 |
|
5'-IDP·Na3; Inosine-5'-diphosphate, trisodium salt
|
|
71672-86-1 |
|
2'-dC·H2O; 2'-Deoxycytidine monohydrate
|
|
652157-52-3 |
|
6-SH-dG; 6-SH-deoxyguanosine
|
|
789-61-7 |
|
2,6-dichlorocapronic acid xylidide
|
|
1037184-07-8 |
|
Cyclo-Cr; 2, 2'-Anhydro-cytidine/Ancitabine
|
|
31698-14-3 |
|
4,6-Pyrimidinediamine, 2-[1-[(2-fluorophenyl)methyl]-1H-pyrazolo[3,4-b]pyridin-3-yl]-5-[(1E)-2-phenyldiazenyl]-
|
|
370879-49-5 |
|
(5S,6S,9R)-6-(2,3-difluorophenyl)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-aminedihydrochloride
|
|
1373116-04-1 |
|
Benzoic acid, 4-[3-(3,5-dichlorophenyl)-4,4,4-trifluoro-3-hydroxy-1-oxobutyl]-2-methyl-
|
|
1095275-07-2 |
|
Benzenamine, 2-[(2,4-dimethylphenyl)thio]-, hydrochloride (1:1)
|
|
1610527-50-8 |
|
2'-deoxy-3'-TMP·Na2; 2'-Deoxythymidine-3'-monophosphate, disodium salt
|
|
108320-91-8 |
|
2-Ethylbenzofuran
|
|
3131-63-3 |
|
Metronidazole benzoate
|
|
13182-89-3 |
|
4,6-dichloro-2-propylthiopyrimidine-5-amine
|
|
1145783-15-9 |
|
O-Benzyl Posaconazole
|
|
170985-86-1 |
|
7-Methoxy-4,4-dimethyl-1H-2-benzopyran-1,3(4H)-dione
|
|
55974-25-9 |
|
3-PyridinecarboxaMide, 2-chloro-N-[4-(1-cyanocyclopentyl)phenyl]
|
|
1158560-99-6 |
|
Garlic oil
|
|
8008-99-9 |
|
(R)-9-((triisopropylsilyl)oxy)-6,7,8,9-tetrahydro-5H-cyclohepta[b]pyridin-5-onehydrochloride
|
|
1190363-45-1 |
|
2-NH2-Ara-Ar; 2, 6-Diaminopurine-9-arabinoside; 9-(β-D-arabinofuranosyl)-2, 6-Diamino-purine
|
|
34079-68-0 |
|
2'-deoxy-3'-CMP·H2; 2'-Deoxycytidine-3'-monophosphate, free acid
|
|
6220-63-9 |
|
8-Hydroxy-Gr; 8-Hydroxyguanosine
|
|
3868-31-3 |
|
D-erythro-Hexonic acid, 2,4,6-trideoxy-3,5-O-(1-methylethylidene)-6-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfonyl]-, 1,1-dimethylethyl ester
|
|
1326302-97-9 |
